To provide support for scaling up global access to multiple micronutrient supplements and other cost effective maternal and child interventions, and for other purposes.

On July 2, 2026, Rep. Young Kim (R-CA) introduced HR9583 in the 119th Congress. The bill aims to scale up global access to multiple micronutrient supplements and other cost-effective maternal and child interventions. It was referred to the House Committee on Foreign Affairs, where it currently sits with no scheduled hearings or markups. The bill has 2 cosponsors, indicating limited momentum. As an authorization bill without explicit funding amounts, any eventual spending would require separate appropriations. The global health supplement market is fragmented and dominated by large diversified companies or private entities. No publicly traded pure-play companies are directly tied to this bill's specific provisions. Given the early legislative stage and lack of funding details, no structural winners or losers can be identified. The bill would need to pass committee, the House, the Senate, and be signed into law before any market impact materializes. This timeline is uncertain and likely years away.